Trophoblast Differentiation and Function (R21 Clinical Trial Optional) | PA 18 047

Opportunity Information: Apply for PA 18 047

The National Institutes of Health (NIH) funding opportunity titled "Trophoblast Differentiation and Function (R21 Clinical Trial Optional)" (Funding Opportunity Number: PA 18-047) is a discretionary grant program designed to spur innovative, early-stage research on how trophoblast cells develop and function during fertility and pregnancy. The central emphasis is on trophoblast differentiation (how these placental cells form and specialize) and trophoblast function (how they behave and interact with the maternal environment), with explicit interest in understanding how the immune system contributes to healthy implantation and placental development or, conversely, to pregnancy complications. Because trophoblast biology sits at the heart of placental formation and maternal-fetal exchange, the NIH frames this topic as foundational science that can open practical pathways toward better diagnostics, prevention strategies, and treatments.

This FOA is motivated by the idea that many serious pregnancy complications share underlying placental or implantation-related mechanisms that are not yet fully understood. By investing in fundamental and mechanistic research, NIH aims to accelerate progress against placental-based pregnancy disorders, including implantation failure, recurrent or frequent pregnancy loss, preeclampsia, fetal growth restriction, and preterm birth. In other words, the opportunity is positioned to support projects that reveal key biological pathways, cellular behaviors, or immune interactions that shape pregnancy outcomes, with the expectation that clearer mechanisms will ultimately translate into clinical advances.

The mechanism is an R21, which is typically used by NIH to support exploratory or high-impact projects that may be at an earlier stage of development than larger R01-style grants. The "Clinical Trial Optional" designation signals that applicants may propose studies that meet NIH’s definition of a clinical trial, but they are not required to do so; non-clinical basic or translational studies are equally within scope as long as they align with the scientific goals described. The listed award ceiling is $200,000, reflecting the smaller, pilot-oriented nature of the R21 mechanism and its role in helping teams generate compelling proof-of-concept data.

Eligibility is broad, reflecting NIH’s intent to draw ideas from many sectors and institution types. Eligible applicants include a range of government entities (state, county, city or township, special district governments), independent school districts, and public housing authorities/Indian housing authorities. Academic eligibility includes public and state-controlled institutions of higher education as well as private institutions of higher education. The FOA also welcomes nonprofit organizations both with and without 501(c)(3) status (as long as they are not institutions of higher education), for-profit organizations (other than small businesses), and small businesses, along with other applicant types. In addition, the announcement highlights inclusion of organizations that broaden geographic and community representation, such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISISs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), and Tribally Controlled Colleges and Universities (TCCUs). It also lists Indian/Native American Tribal Governments (other than federally recognized), eligible federal agencies, faith-based or community-based organizations, U.S. territories or possessions, regional organizations, and non-U.S. entities (foreign organizations), signaling an openness to both domestic and international expertise where appropriate.

From an administrative standpoint, the opportunity is categorized as a grant within the Health, Income Security and Social Services activity area, and it is associated with CFDA numbers 93.855, 93.856, and 93.865. The NIH is the sponsoring agency. The source data notes a creation date of 2017-11-15 and an original closing date of 2020-01-07, which is important for applicants to interpret as a historically posted opportunity; anyone looking to apply would typically need to confirm whether the FOA is still active, has been reissued, or has successor announcements with updated dates and requirements.

Overall, this grant opportunity is aimed at researchers who can bring fresh experimental approaches to trophoblast development and placental biology, including maternal immune interactions, to clarify why some pregnancies fail at implantation or develop placental dysfunction later in gestation. By supporting exploratory studies under the R21 framework, NIH is encouraging investigators to test novel hypotheses, develop new models or measurement strategies, and generate the kind of mechanistic evidence that can serve as a springboard for larger studies and, eventually, improved clinical interventions for major pregnancy disorders.

• The National Institutes of Health in the health, income security and social services sector is offering a public funding opportunity titled "Trophoblast Differentiation and Function (R21 Clinical Trial Optional)" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.855, 93.856, 93.865.
• This funding opportunity was created on 2017-11-15.
• Applicants must submit their applications by 2020-01-07. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• Each selected applicant is eligible to receive up to $200,000.00 in funding.
• Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.

Apply for PA 18 047

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: